Baseline Cardiac Biomarker Levels as Predictors of Cancer Risk in the MESA Cohort
Open Access
- 16 June 2025
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 4 (7) , 101884
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 53 references indexed in Scilit:
- Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-AnalysisThe American Journal of Cardiology, 2023
- Resistin and Risks of Incident Heart Failure Subtypes and Cardiac Fibrosis: The Multi-Ethnic Study of AtherosclerosisESC Heart Failure, 2022
- Cardiovascular Disease Risk Among Cancer SurvivorsJACC, 2022
- Multi-Ethnic Study of Atherosclerosis (MESA)JACC, 2021
- Cardiovascular Risk Factors Are Associated With Future CancerJACC: Cardiooncology, 2021
- Common Mechanistic Pathways in Cancer and Heart Failure. A Scientific Roadmap on Behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Journal of Heart Failure, 2020
- Troponins and Brain Natriuretic Peptides for the Prediction of Cardiotoxicity in Cancer Patients: A Meta-AnalysisEuropean Journal of Heart Failure, 2019
- Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivorsCancer Medicine, 2018
- Legacy of MESAGlobal Heart, 2016
- Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseasesEuropean Journal of Internal Medicine, 2011